The World Contract Research and Manufacturing Market, 2006-2011 - Trends in Outsourcing

The Contract Pharma market in 2005 was worth an estimated $57bn. Attitudes within the pharmaceutical industry are slowly changing and the use of strategic outsourcing is becoming an accepted practice. Specialised technologies and a global presence are becoming more important for a greater number of pharmaceutical companies. Even big pharma is increasingly using outsourcing to spread the risk of development and lower fixed costs.

So what next for the contract pharma market? Read visiongain's brand new report to find out.

The following issues are covered in detail:

> A summary of the relevant recent changes in contract pharma

> A market forecast for the world contract research and contract manufacturing markets 2006-2011

> A discussion of relevant regulations

> The growing importance of biotechnology outsourcing

> A comprehensive review of review of the decision to outsourcing

> Selected company profiles

Why should you buy this report?

Visiongain predicts that the pharmaceutical industry will undergo a period of intense change in the years to come and contract pharma services will play a large role in that change. People from all sides of the industry should read this report to keep up to date with this maturing, yet dynamic sector.

Lead Analyst: Dr Tom Newton Publication Date: 03/08/06 Pages: 121

Single user licence: The Report is delivered via an on-line reading room. One use access only, the report is in Flash format in a printable format.

Department: Report is delivered via an on line reading room. Five user access only, the report is in Flash format in a printable format.

Company/site wide licence: The report is delivered in email format as a PDF document with no locking system attached. The report can be loaded onto the company's intranet site.
Table of Contents

Price
Single User Licence $2998.00
Department Licence 5 Users $5998.00
Company-wide Intranet Licence $9998.00